The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Estrogen and Progesterone-Global Market Insights and Sales Trends 2024

Estrogen and Progesterone-Global Market Insights and Sales Trends 2024

Publishing Date : Nov, 2023

License Type :
 

Report Code : 1834475

No of Pages : 119

Ask Your Query
Synopsis
Progesterone and estrogen are the two most important hormones in the female body. These are steroid hormones that are responsible for various female characteristics in the body.
The global Estrogen and Progesterone market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Estrogen and Progesterone in various end use industries. The expanding demands from the Pharmacy, Hospital and Department of Endocrinology,, are propelling Estrogen and Progesterone market. Estrogen, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Progesterone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Estrogen and Progesterone market, driven by demand from China, the second largest economy with some signs of stabilising, the Estrogen and Progesterone market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Estrogen and Progesterone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Estrogen and Progesterone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Estrogen and Progesterone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Estrogen and Progesterone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Estrogen and Progesterone covered in this report include Gedeon Richter, Bayer, N.V.Organon, Pfizer Healthcare, Jenapharm, Besins Healthcare, MERCK SERONO, Abbott and Teva Pharma, etc.
The global Estrogen and Progesterone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gedeon Richter
Bayer
N.V.Organon
Pfizer Healthcare
Jenapharm
Besins Healthcare
MERCK SERONO
Abbott
Teva Pharma
Aspen Pharmacare
Dr.Kade Pharmazeutische Fabrik
F.I.S.-FABBRICA
Eli Lilly
Orion
AstraZeneca
Novartis Pharma
Novo Nordisk
Global Estrogen and Progesterone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Estrogen and Progesterone market, Segment by Type:
Estrogen
Progesterone
Global Estrogen and Progesterone market, by Application
Pharmacy
Hospital
Department of Endocrinology
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Estrogen and Progesterone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Estrogen and Progesterone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Estrogen and Progesterone Market Overview
1.1 Estrogen and Progesterone Product Overview
1.2 Estrogen and Progesterone Market Segment by Type
1.2.1 Estrogen
1.2.2 Progesterone
1.3 Global Estrogen and Progesterone Market Size by Type
1.3.1 Global Estrogen and Progesterone Market Size Overview by Type (2018-2029)
1.3.2 Global Estrogen and Progesterone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Estrogen and Progesterone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Estrogen and Progesterone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Estrogen and Progesterone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Estrogen and Progesterone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Estrogen and Progesterone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Estrogen and Progesterone Sales Breakdown by Type (2018-2023)
2 Global Estrogen and Progesterone Market Competition by Company
2.1 Global Top Players by Estrogen and Progesterone Sales (2018-2023)
2.2 Global Top Players by Estrogen and Progesterone Revenue (2018-2023)
2.3 Global Top Players by Estrogen and Progesterone Price (2018-2023)
2.4 Global Top Manufacturers Estrogen and Progesterone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Estrogen and Progesterone Market Competitive Situation and Trends
2.5.1 Estrogen and Progesterone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Estrogen and Progesterone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Estrogen and Progesterone as of 2022)
2.7 Date of Key Manufacturers Enter into Estrogen and Progesterone Market
2.8 Key Manufacturers Estrogen and Progesterone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Estrogen and Progesterone Status and Outlook by Region
3.1 Global Estrogen and Progesterone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Estrogen and Progesterone Historic Market Size by Region
3.2.1 Global Estrogen and Progesterone Sales in Volume by Region (2018-2023)
3.2.2 Global Estrogen and Progesterone Sales in Value by Region (2018-2023)
3.2.3 Global Estrogen and Progesterone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Estrogen and Progesterone Forecasted Market Size by Region
3.3.1 Global Estrogen and Progesterone Sales in Volume by Region (2024-2029)
3.3.2 Global Estrogen and Progesterone Sales in Value by Region (2024-2029)
3.3.3 Global Estrogen and Progesterone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Estrogen and Progesterone by Application
4.1 Estrogen and Progesterone Market Segment by Application
4.1.1 Pharmacy
4.1.2 Hospital
4.1.3 Department of Endocrinology
4.2 Global Estrogen and Progesterone Market Size by Application
4.2.1 Global Estrogen and Progesterone Market Size Overview by Application (2018-2029)
4.2.2 Global Estrogen and Progesterone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Estrogen and Progesterone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Estrogen and Progesterone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Estrogen and Progesterone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Estrogen and Progesterone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Estrogen and Progesterone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Estrogen and Progesterone Sales Breakdown by Application (2018-2023)
5 North America Estrogen and Progesterone by Country
5.1 North America Estrogen and Progesterone Historic Market Size by Country
5.1.1 North America Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Estrogen and Progesterone Sales in Volume by Country (2018-2023)
5.1.3 North America Estrogen and Progesterone Sales in Value by Country (2018-2023)
5.2 North America Estrogen and Progesterone Forecasted Market Size by Country
5.2.1 North America Estrogen and Progesterone Sales in Volume by Country (2024-2029)
5.2.2 North America Estrogen and Progesterone Sales in Value by Country (2024-2029)
6 Europe Estrogen and Progesterone by Country
6.1 Europe Estrogen and Progesterone Historic Market Size by Country
6.1.1 Europe Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Estrogen and Progesterone Sales in Volume by Country (2018-2023)
6.1.3 Europe Estrogen and Progesterone Sales in Value by Country (2018-2023)
6.2 Europe Estrogen and Progesterone Forecasted Market Size by Country
6.2.1 Europe Estrogen and Progesterone Sales in Volume by Country (2024-2029)
6.2.2 Europe Estrogen and Progesterone Sales in Value by Country (2024-2029)
7 Asia-Pacific Estrogen and Progesterone by Region
7.1 Asia-Pacific Estrogen and Progesterone Historic Market Size by Region
7.1.1 Asia-Pacific Estrogen and Progesterone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Estrogen and Progesterone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Estrogen and Progesterone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Estrogen and Progesterone Forecasted Market Size by Region
7.2.1 Asia-Pacific Estrogen and Progesterone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Estrogen and Progesterone Sales in Value by Region (2024-2029)
8 Latin America Estrogen and Progesterone by Country
8.1 Latin America Estrogen and Progesterone Historic Market Size by Country
8.1.1 Latin America Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Estrogen and Progesterone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Estrogen and Progesterone Sales in Value by Country (2018-2023)
8.2 Latin America Estrogen and Progesterone Forecasted Market Size by Country
8.2.1 Latin America Estrogen and Progesterone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Estrogen and Progesterone Sales in Value by Country (2024-2029)
9 Middle East and Africa Estrogen and Progesterone by Country
9.1 Middle East and Africa Estrogen and Progesterone Historic Market Size by Country
9.1.1 Middle East and Africa Estrogen and Progesterone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Estrogen and Progesterone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Estrogen and Progesterone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Estrogen and Progesterone Forecasted Market Size by Country
9.2.1 Middle East and Africa Estrogen and Progesterone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Estrogen and Progesterone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Gedeon Richter
10.1.1 Gedeon Richter Company Information
10.1.2 Gedeon Richter Introduction and Business Overview
10.1.3 Gedeon Richter Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Gedeon Richter Estrogen and Progesterone Products Offered
10.1.5 Gedeon Richter Recent Development
10.2 Bayer
10.2.1 Bayer Company Information
10.2.2 Bayer Introduction and Business Overview
10.2.3 Bayer Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer Estrogen and Progesterone Products Offered
10.2.5 Bayer Recent Development
10.3 N.V.Organon
10.3.1 N.V.Organon Company Information
10.3.2 N.V.Organon Introduction and Business Overview
10.3.3 N.V.Organon Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 N.V.Organon Estrogen and Progesterone Products Offered
10.3.5 N.V.Organon Recent Development
10.4 Pfizer Healthcare
10.4.1 Pfizer Healthcare Company Information
10.4.2 Pfizer Healthcare Introduction and Business Overview
10.4.3 Pfizer Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Healthcare Estrogen and Progesterone Products Offered
10.4.5 Pfizer Healthcare Recent Development
10.5 Jenapharm
10.5.1 Jenapharm Company Information
10.5.2 Jenapharm Introduction and Business Overview
10.5.3 Jenapharm Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Jenapharm Estrogen and Progesterone Products Offered
10.5.5 Jenapharm Recent Development
10.6 Besins Healthcare
10.6.1 Besins Healthcare Company Information
10.6.2 Besins Healthcare Introduction and Business Overview
10.6.3 Besins Healthcare Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Besins Healthcare Estrogen and Progesterone Products Offered
10.6.5 Besins Healthcare Recent Development
10.7 MERCK SERONO
10.7.1 MERCK SERONO Company Information
10.7.2 MERCK SERONO Introduction and Business Overview
10.7.3 MERCK SERONO Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 MERCK SERONO Estrogen and Progesterone Products Offered
10.7.5 MERCK SERONO Recent Development
10.8 Abbott
10.8.1 Abbott Company Information
10.8.2 Abbott Introduction and Business Overview
10.8.3 Abbott Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Abbott Estrogen and Progesterone Products Offered
10.8.5 Abbott Recent Development
10.9 Teva Pharma
10.9.1 Teva Pharma Company Information
10.9.2 Teva Pharma Introduction and Business Overview
10.9.3 Teva Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Teva Pharma Estrogen and Progesterone Products Offered
10.9.5 Teva Pharma Recent Development
10.10 Aspen Pharmacare
10.10.1 Aspen Pharmacare Company Information
10.10.2 Aspen Pharmacare Introduction and Business Overview
10.10.3 Aspen Pharmacare Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Aspen Pharmacare Estrogen and Progesterone Products Offered
10.10.5 Aspen Pharmacare Recent Development
10.11 Dr.Kade Pharmazeutische Fabrik
10.11.1 Dr.Kade Pharmazeutische Fabrik Company Information
10.11.2 Dr.Kade Pharmazeutische Fabrik Introduction and Business Overview
10.11.3 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Dr.Kade Pharmazeutische Fabrik Estrogen and Progesterone Products Offered
10.11.5 Dr.Kade Pharmazeutische Fabrik Recent Development
10.12 F.I.S.-FABBRICA
10.12.1 F.I.S.-FABBRICA Company Information
10.12.2 F.I.S.-FABBRICA Introduction and Business Overview
10.12.3 F.I.S.-FABBRICA Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.12.4 F.I.S.-FABBRICA Estrogen and Progesterone Products Offered
10.12.5 F.I.S.-FABBRICA Recent Development
10.13 Eli Lilly
10.13.1 Eli Lilly Company Information
10.13.2 Eli Lilly Introduction and Business Overview
10.13.3 Eli Lilly Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Eli Lilly Estrogen and Progesterone Products Offered
10.13.5 Eli Lilly Recent Development
10.14 Orion
10.14.1 Orion Company Information
10.14.2 Orion Introduction and Business Overview
10.14.3 Orion Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Orion Estrogen and Progesterone Products Offered
10.14.5 Orion Recent Development
10.15 AstraZeneca
10.15.1 AstraZeneca Company Information
10.15.2 AstraZeneca Introduction and Business Overview
10.15.3 AstraZeneca Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.15.4 AstraZeneca Estrogen and Progesterone Products Offered
10.15.5 AstraZeneca Recent Development
10.16 Novartis Pharma
10.16.1 Novartis Pharma Company Information
10.16.2 Novartis Pharma Introduction and Business Overview
10.16.3 Novartis Pharma Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Novartis Pharma Estrogen and Progesterone Products Offered
10.16.5 Novartis Pharma Recent Development
10.17 Novo Nordisk
10.17.1 Novo Nordisk Company Information
10.17.2 Novo Nordisk Introduction and Business Overview
10.17.3 Novo Nordisk Estrogen and Progesterone Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Novo Nordisk Estrogen and Progesterone Products Offered
10.17.5 Novo Nordisk Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Estrogen and Progesterone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Estrogen and Progesterone Industrial Chain Analysis
11.4 Estrogen and Progesterone Market Dynamics
11.4.1 Estrogen and Progesterone Industry Trends
11.4.2 Estrogen and Progesterone Market Drivers
11.4.3 Estrogen and Progesterone Market Challenges
11.4.4 Estrogen and Progesterone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Estrogen and Progesterone Distributors
12.3 Estrogen and Progesterone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock